GET DAILY SIGNALSNOV Inc. (NOV) Prepares for Q3 2026 Earnings After +28% YTD Climb
Key Takeaways
- NOV Inc. (NYSE: NOV) is scheduled to report its third quarter 2026 results after the market closes on Tuesday, October 27, 2026.
- Wall Street consensus points to earnings of roughly $0.25 per share on revenue near $2.19 billion, compared with $0.11 per share on $2.18 billion a year ago.
- The company enters this report on strong footing after beating expectations in Q2 2026, when it posted $0.31 per share versus a $0.17 consensus estimate.
- Investors will be watching margins closely, as sequential revenue growth is expected to outpace the quarterly earnings-per-share comparison.
- Management's commentary on offshore activity, capital equipment demand, and cost control will be central to the market's read of the quarter.
- For more on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, be sure to explore these dedicated pages.
- To discover additional trade ideas and market signals, explore Trending AI Robots.
Why This Earnings Report Matters
NOV Inc., a Houston-based provider of technology and equipment for the global energy industry, is reporting against a backdrop of firming oilfield services demand, particularly in offshore and deepwater development. The third-quarter report carries added weight because it follows a second quarter in which the company materially exceeded consensus, lifting investor expectations for sustained profitability. With revenue projected to edge higher sequentially while earnings per share are forecast to moderate, the release will test whether recent margin gains can be maintained. How management frames pricing, cost efficiency, and backlog conversion will help investors gauge the durability of the company's operational turnaround. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Q3 2026 Earnings Expectations
For the third quarter of 2026, analysts expect NOV to report EPS of approximately $0.25, with estimates ranging from about $0.19 to $0.30, on revenue of roughly $2.19 billion. That revenue figure implies a modest year-over-year increase from the $2.18 billion recorded in the same period a year ago, while the EPS estimate would more than double the $0.11 reported in Q3 2025.
The sequential comparison is the focal point. In Q2 2026, NOV delivered $0.31 per share against a $0.17 estimate and $2.13 billion in revenue, a substantial beat. Management guided for consolidated revenue to rise both sequentially and year over year, with the Energy Equipment segment expected to decline 1% to 3% year over year and the Energy Products segment expected to grow 5% to 7% year over year. Investors will watch whether profitability tracks that top-line trajectory or whether segment mix and cost pressures temper margins.
Market Sentiment and Recent Performance
Sentiment heading into the release is cautiously constructive. NOV shares have climbed roughly 28% year to date, though the stock has traded below its 52-week high near $21.93. Analysts remain largely neutral on the name, with a consensus price target around $22; Citi recently trimmed its target to $21 from $22 while maintaining a Neutral rating. The stock's recent earnings reactions have been mixed, with shares declining the day after the Q2 report despite the strong beat, and the shares have shown a negative post-earnings drift since that release. This pattern places added emphasis on guidance and margin commentary, rather than headline EPS alone, as the likely drivers of the next move.
Forward Outlook and Key Factors to Monitor
After the print, investors should watch how management frames the gap between revenue growth and the expected sequential step-down in earnings per share. If the company cites favorable mix, disciplined pricing, or improving operating leverage, it could signal that the Q2 margin strength was not a one-off. Conversely, commentary pointing to higher costs, competitive pricing pressure, or softer-than-expected bookings would raise questions about the durability of the recovery.
Beyond the headline numbers, the segment-level trajectory matters. Strength in Energy Products and stabilization in Energy Equipment would support the view that NOV is capturing demand tied to offshore and efficient production technologies. Order intake and backlog trends will also be important forward indicators, since they offer a window into future revenue visibility across the company's capital equipment and aftermarket businesses.
Finally, watch for any updates on full-year guidance and the macro outlook for global drilling and completion activity. As the broader oilfield services market expands, NOV's ability to translate that demand into higher-margin, technology-driven revenue will be the key narrative investors assess in the quarters ahead.
AI Tools in Earnings Analysis
In preparing for reports like this one, I often turn to Tickeron’s AI Screener to quickly surface comparable names in the energy sector and check technical setups alongside fundamentals. It helps narrow focus on momentum shifts or valuation gaps that might otherwise take hours to review manually. Combined with AI Daily Buy/Sell Signals for timing context, these tools support a more structured review of the data without replacing core fundamental work.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NOV's RSI Indicator recovers from oversold territory
The RSI Oscillator for NOV moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 20 of the 24 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on NOV as a result. In 71 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for NOV just turned positive on October 16, 2026. Looking at past instances where NOV's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.
NOV moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOV advanced for three days, in 234 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for NOV crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
NOV broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NOV entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. NOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock slightly better than average.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.160) is normal, around the industry mean (1.624). P/E Ratio (74.778) is within average values for comparable stocks, (-32.247). Projected Growth (PEG Ratio) (0.787) is also within normal values, averaging (1.687). Dividend Yield (0.018) settles around the average of (0.036) among similar stocks. P/S Ratio (0.873) is also within normal values, averaging (1.663).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company which engages in manufacturing of oil & gas drilling field machinery and equipment
Industry OilfieldServicesEquipment
Advertisement